How to achieve international action on falsified and substandard medicines

Abstract

Substandard and falsified medicines kill patients, yet progress on the twin challenges of safeguarding the quality of genuine medicine and criminalising falsified ones has been held back by controversy over intellectual property rights and confusion over terms. <b>Amir Attaran and colleagues</b> propose a global treaty to overcome the problems